Skip to main content
NCBI home page
British Journal of Experimental Pathology logoLink to British Journal of Experimental Pathology
. 1989 Jun;70(3):327–335.

Serum amyloid A gene expression and AA amyloid formation in A/J and SJL/J mice.

H Rokita 1, T Shirahama 1, A S Cohen 1, J D Sipe 1
PMCID: PMC2040574  PMID: 2765389

Abstract

Serum amyloid A (SAA) gene expression and AA amyloid fibril formation were studied in A/J and SJL/J mice, two strains which have been reported to possess defects in AA fibril formation. Four types of inflammatory stimulation were employed: acute inflammation stimulated with lipopolysaccharide (LPS), chronic inflammation with casein in complete Freund's adjuvant, amyloidosis with injection of amyloid enhancing factor (AEF) together with casein in complete Freund's adjuvant, and non-amyloidogenic inflammation in the presence of AEF with injection of AEF together with LPS. Both A/J and SJL/J mice developed splenic amyloidosis 1 day after initiation of chronic inflammation in the presence of AEF. No amyloid deposits were detected during any of the other types of inflammation. Amyloidotic mice exhibited decreased amounts of SAA mRNA in liver and spleen concomitant with decreased amounts of SAA in serum. Alpha-I-acid glycoprotein mRNA was present in liver throughout the course of AEF accelerated amyloidosis, indicating that decreased SAA gene expression and AA fibril formation is not part of a general inhibitory effect of AEF on protein synthesis.

Full text

PDF
327

Images in this article

330Fig. 1
on p.330
331p331-a
on p.331

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baltz M. L., Rowe I. F., Caspi D., Turnell W. G., Pepys M. B. Is the serum amyloid A protein in acute phase plasma high density lipoprotein the precursor of AA amyloid fibrils? Clin Exp Immunol. 1986 Dec;66(3):701–708. [PMC free article] [PubMed] [Google Scholar]
  2. Baumann H., Berger F. G. Genetics and evolution of the acute phase proteins in mice. Mol Gen Genet. 1985;201(3):505–512. doi: 10.1007/BF00331347. [DOI] [PubMed] [Google Scholar]
  3. Baumann H., Held W. A., Berger F. G. The acute phase response of mouse liver. Genetic analysis of the major acute phase reactants. J Biol Chem. 1984 Jan 10;259(1):566–573. [PubMed] [Google Scholar]
  4. Benditt E. P., Eriksen N., Hermodson M. A., Ericsson L. H. The major proteins of human and monkey amyloid substance: Common properties including unusual N-terminal amino acid sequences. FEBS Lett. 1971 Dec 1;19(2):169–173. doi: 10.1016/0014-5793(71)80506-9. [DOI] [PubMed] [Google Scholar]
  5. Benson M. D., Scheinberg M. A., Shirahama T., Cathcart E. S., Skinner M. Kinetics of serum amyloid protein A in casein-induced murine amyloidosis. J Clin Invest. 1977 Mar;59(3):412–417. doi: 10.1172/JCI108654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brandwein S. R., Sipe J. D., Skinner M., Cohen A. S. Effect of colchicine on experimental amyloidosis in two CBA/J mouse models. Chronic inflammatory stimulation and administration of amyloid-enhancing factor during acute inflammation. Lab Invest. 1985 Mar;52(3):319–325. [PubMed] [Google Scholar]
  7. Cohen A. S., Shirahama T. Animal model for human disease: spontaneous and induced amyloidosis. Am J Pathol. 1972 Aug;68(2):441–444. [PMC free article] [PubMed] [Google Scholar]
  8. Evans C. H. The role of lymphotoxin in natural cell-mediated cytotoxicity. Cell Immunol. 1981 Sep 1;63(1):1–15. doi: 10.1016/0008-8749(81)90024-1. [DOI] [PubMed] [Google Scholar]
  9. Gertz M. A., Skinner M., Sipe J. D., Cohen A. S., Kyle R. A. Serum amyloid A protein and C-reactive protein in systemic amyloidosis. Clin Exp Rheumatol. 1985 Oct-Dec;3(4):317–320. [PubMed] [Google Scholar]
  10. Goedert M. Neuronal localization of amyloid beta protein precursor mRNA in normal human brain and in Alzheimer's disease. EMBO J. 1987 Dec 1;6(12):3627–3632. doi: 10.1002/j.1460-2075.1987.tb02694.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gotto A. M., Jr, Pownall H. J., Havel R. J. Introduction to the plasma lipoproteins. Methods Enzymol. 1986;128:3–41. doi: 10.1016/0076-6879(86)28061-1. [DOI] [PubMed] [Google Scholar]
  12. Hoffman J. S., Ericsson L. H., Eriksen N., Walsh K. A., Benditt E. P. Murine tissue amyloid protein AA. NH2-terminal sequence identity with only one of two serum amyloid protein (ApoSAA) gene products. J Exp Med. 1984 Feb 1;159(2):641–646. doi: 10.1084/jem.159.2.641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kisilevsky R. Amyloidosis: a familiar problem in the light of current pathogenetic developments. Lab Invest. 1983 Oct;49(4):381–390. [PubMed] [Google Scholar]
  14. Lowell C. A., Potter D. A., Stearman R. S., Morrow J. F. Structure of the murine serum amyloid A gene family. Gene conversion. J Biol Chem. 1986 Jun 25;261(18):8442–8452. [PubMed] [Google Scholar]
  15. McAdam K. P., Sipe J. D. Murine model for human secondary amyloidosis: genetic variability of the acute-phase serum protein SAA response to endotoxins and casein. J Exp Med. 1976 Oct 1;144(4):1121–1127. doi: 10.1084/jem.144.4.1121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Prelli F., Pras M., Frangione B. Degradation and deposition of amyloid AA fibrils are tissue specific. Biochemistry. 1987 Dec 15;26(25):8251–8256. doi: 10.1021/bi00399a035. [DOI] [PubMed] [Google Scholar]
  17. Ramadori G., Sipe J. D., Dinarello C. A., Mizel S. B., Colten H. R. Pretranslational modulation of acute phase hepatic protein synthesis by murine recombinant interleukin 1 (IL-1) and purified human IL-1. J Exp Med. 1985 Sep 1;162(3):930–942. doi: 10.1084/jem.162.3.930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Rokita H., Shirahama T., Cohen A. S., Meek R. L., Benditt E. P., Sipe J. D. Differential expression of the amyloid SAA 3 gene in liver and peritoneal macrophages of mice undergoing dissimilar inflammatory episodes. J Immunol. 1987 Dec 1;139(11):3849–3853. [PubMed] [Google Scholar]
  19. Sipe J. D., Colten H. R., Goldberger G., Edge M. D., Tack B. F., Cohen A. S., Whitehead A. S. Human serum amyloid A (SAA): biosynthesis and postsynthetic processing of preSAA and structural variants defined by complementary DNA. Biochemistry. 1985 Jun 4;24(12):2931–2936. doi: 10.1021/bi00333a018. [DOI] [PubMed] [Google Scholar]
  20. Sipe J. D., McAdam K. P., Uchino F. Biochemical evidence for the biphasic development of experimental amyloidosis. Lab Invest. 1978 Jan;38(1):110–114. [PubMed] [Google Scholar]
  21. Stearman R. S., Lowell C. A., Peltzman C. G., Morrow J. F. The sequence and structure of a new serum amyloid A gene. Nucleic Acids Res. 1986 Jan 24;14(2):797–809. doi: 10.1093/nar/14.2.797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. TEILUM G. PATHOGENESIS OF AMYLOIDOSIS. Acta Pathol Microbiol Scand. 1964;61:21–45. doi: 10.1111/apm.1964.61.1.21. [DOI] [PubMed] [Google Scholar]
  23. Taylor B. A., Rowe L. Genes for serum amyloid A proteins map to Chromosome 7 in the mouse. Mol Gen Genet. 1984;195(3):491–499. doi: 10.1007/BF00341452. [DOI] [PubMed] [Google Scholar]
  24. Wohlgethan J. R., Cathcart E. S. Amyloid resistance in A/J mice. Studies with a transfer model. Lab Invest. 1980 Jun;42(6):663–667. [PubMed] [Google Scholar]
  25. Yamamoto K., Shiroo M., Migita S. Diverse gene expression for isotypes of murine serum amyloid A protein during acute phase reaction. Science. 1986 Apr 11;232(4747):227–229. doi: 10.1126/science.3456645. [DOI] [PubMed] [Google Scholar]

Articles from British journal of experimental pathology are provided here courtesy of Wiley

RESOURCES